We have received your feedback.Thank you for taking your time in view of your busy schedule.
| Weekly News | Amount |
|---|---|
|
Total
|
${lastRankDetail.pages.length} |
| Financing | ${lastRankDetail.financing_pages.length} |
| Product | ${lastRankDetail.product_pages.length} |
| Negative | ${lastRankDetail.sentiment_pages.length} |
NuProbe's TOE HOLD PROBE - based technology is the initial research and development at Harvard University's Vis Institute of Bioengineering and Rice University, and is authorized by its patent. This is a breakthrough molecular technology that can be used to detect various diseases including cancer. NuProbe's technology can very sensitively identify mutants in the early stage, improve the detection rate of diseases and help guide treatment decisions that can increase patients' chances of survival
Transactions
Research
Competition
Transactions
Funding
1 Fundings
| Date | Amount | Round | Relative News |
|---|---|---|---|
| Apr 2018 | 11 million USD | Series A | Investment News | NuProbe completed a round of 11 million US dollars in financing, with Sequoia Capital China and Scarlett Jianxin Fund jointly leading the investment |
Signals
Events
${currentEventsPage.count} Events
| Events (${currentEventsPage.count}) | Date |
|---|---|
| Nothing Happens :-( | |
| ${e.desp} | ${e.date} |
News
${ rankDetail.pages.length } News Articles
${currentTimeRange.start} ~ ${currentTimeRange.end}
| Article (${rankDetail.pages.length}) | Tag |
|---|---|
| ${article.en_title} | ${article.tag} |
Industry Financing Info
Research
Intelligence
0 Research Briefs
Competition
Competitors
4 Competitors
